— Know what they know.
Not Investment Advice
Also trades as: 0P59.L (LSE) · $vol 0M · CPA.DE (XETRA) · $vol 0M

CL NYSE

Colgate-Palmolive Company
1W: -2.1% 1M: -6.5% 3M: -9.2% YTD: +9.1% 1Y: +7.4% 3Y: +25.0% 5Y: +21.7%
$84.26
-0.27 (-0.32%)
 
Weekly Expected Move ±1.9%
$81 $83 $84 $86 $88
NYSE · Consumer Defensive · Household & Personal Products · Tech Score Strong Sell · Power 42 · $67.4B mcap · 748M float · 0.660% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.0 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 47.5%
Cost Advantage
70
Intangibles
51
Switching Cost
54
Network Effect
50
Scale ★
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CL has a Narrow competitive edge (59.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 47.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$95
Low
$103
Avg Target
$109
High
Based on 5 analysts since Jul 31, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 18Hold: 25Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$101.33
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-21 Piper Sandler — $92 $95 +3 +8.6% $87.47
2026-08-03 RBC Capital Nik Modi $102 $104 +2 +13.5% $91.67
2026-08-03 Deutsche Bank — $99 $101 +2 +10.6% $91.31
2026-08-03 Morgan Stanley — $100 $104 +4 +12.6% $92.40
2026-08-03 UBS — $100 $109 +9 +18.1% $92.29
2026-07-08 Wells Fargo Chris Carey $92 $95 +3 -0.0% $95.03
2026-06-11 Bernstein Cristian Rios Initiated $96 — +7.4% $89.39
2026-05-04 UBS — $93 $100 +7 +17.0% $85.50
2026-05-04 Deutsche Bank Steve Powers $86 $99 +13 +15.4% $85.78
2026-04-21 Redburn Partners — $93 $100 +7 +19.7% $83.53
2026-04-14 Barclays Lauren Lieberman $88 $79 -9 -5.9% $83.94
2026-04-09 RBC Capital — $88 $102 +14 +18.5% $86.04
2026-04-08 Piper Sandler — $96 $92 -4 +7.5% $85.55
2026-04-08 Wells Fargo Chris Carey $94 $92 -2 +7.5% $85.55
2026-02-20 Goldman Sachs Bonnie Herzog $94 $100 +6 +5.2% $95.09
2026-02-13 Redburn Partners — Initiated $93 — -3.3% $96.17
2026-02-03 Barclays Lauren Lieberman $83 $88 +5 -4.2% $91.89
2026-02-02 Morgan Stanley Dara Mohsenian $87 $100 +13 +10.8% $90.29
2026-02-01 Wells Fargo — $86 $94 +8 +4.1% $90.29
2026-01-30 Goldman Sachs Bonnie Herzog $95 $94 -1 +4.1% $90.29
2026-01-30 Piper Sandler — $88 $96 +8 +7.3% $89.45
2026-01-16 Barclays Lauren Lieberman $82 $83 +1 -1.6% $84.31
2026-01-14 UBS Peter Grom $92 $93 +1 +11.7% $83.27
2026-01-13 Wells Fargo — $100 $86 -14 +5.0% $81.93
2026-01-06 Piper Sandler — $84 $88 +4 +14.0% $77.20
2025-12-16 Jefferies — $89 $85 -4 +7.7% $78.95
2025-12-09 RBC Capital — Initiated $88 — +15.6% $76.11
2025-11-03 Evercore ISI Robert Ottenstein $96 $94 -2 +24.3% $75.62
2025-11-03 Morgan Stanley Dara Mohsenian $96 $87 -9 +13.6% $76.57
2025-10-10 Deutsche Bank — $98 $86 -12 +10.5% $77.81
2025-10-08 UBS — $90 $92 +2 +17.0% $78.64
2025-10-03 Piper Sandler — $121 $84 -37 +7.3% $78.31
2025-10-01 Barclays Lauren Lieberman $89 $82 -7 +2.6% $79.94
2025-08-04 Morgan Stanley — $103 $96 -7 +15.2% $83.36
2025-03-27 Barclays — $80 $89 +9 -4.5% $93.19
2024-09-23 Piper Sandler Korinne Wolfmeyer Initiated $121 — +17.1% $103.31
2024-09-16 Wells Fargo Chris Carey $81 $100 +19 -5.4% $105.73
2024-07-22 Stifel Nicolaus Mark Astrachan $95 $105 +10 +7.1% $98.08
2024-05-28 Morgan Stanley Dara Mohsenian $82 $103 +21 +10.4% $93.30
2024-05-15 Argus Research Chris Graja Initiated $107 — +13.1% $94.57
2024-04-29 Deutsche Bank Steve Powers $87 $98 +11 +8.7% $90.12
2024-04-29 Stifel Nicolaus Mark Astrachan $94 $95 +1 +4.4% $91.01
2024-04-10 Stifel Nicolaus Mark Astrachan $88 $94 +6 +7.2% $87.65
2024-04-08 Evercore ISI Robert Ottenstein Initiated $96 — +9.2% $87.88
2024-01-29 Raymond James Olivia Tong Initiated $91 — +8.7% $83.72
2023-07-27 Wells Fargo Chris Casey $75 $81 +6 +7.1% $75.62
2023-01-13 J.P. Morgan — $78 $86 +8 +10.8% $77.61
2023-01-03 Barclays — $74 $80 +6 +2.5% $78.02
2022-12-06 Deutsche Bank — $88 $87 -1 +12.9% $77.05
2022-10-18 Credit Suisse Kaumil Gajrawala $90 $85 -5 +16.7% $72.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CL receives an overall rating of B. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-07-22 B+ B
2026-07-01 B B+
2026-06-05 B+ B
2026-06-05 B B+
2026-06-04 B+ B
2026-06-03 B B+
2026-06-02 B+ B
2026-06-01 B B+
2026-05-28 B+ B
2026-05-27 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 61 Grade B
Profitability
72
Balance Sheet
46
Earnings Quality
62
Growth
49
Value
39
Momentum
58
Safety
100
Cash Flow
72
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CL scores highest in Safety (100/100) and lowest in Value (39/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.88
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✗ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-3.14
Unlikely Manipulator
Ohlson O-Score
-5.71
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
A+
Score: 76.8/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 2.19x
Accruals: -14.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CL scores 6.88, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CL scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CL's score of -3.14 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CL's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CL receives an estimated rating of A+ (score: 76.8/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CL's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
33.12x
PEG
-1.14x
P/S
3.20x
P/B
284.40x
P/FCF
19.15x
P/OCF
16.58x
EV/EBITDA
20.94x
EV/Revenue
3.82x
EV/EBIT
25.15x
EV/FCF
20.83x
Earnings Yield
2.76%
FCF Yield
5.22%
Shareholder Yield
3.13%
Graham Number
$4.08
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 33.1x earnings, CL commands a growth premium. Graham's intrinsic value formula yields $4.08 per share, 1964% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.693
NI / EBT
×
Interest Burden
0.920
EBT / EBIT
×
EBIT Margin
0.152
EBIT / Rev
×
Asset Turnover
1.229
Rev / Assets
×
Equity Multiplier
36.525
Assets / Equity
=
ROE
434.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CL's ROE of 434.3% is driven by financial leverage (equity multiplier: 36.52x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
11.97%
Fair P/E
32.44x
Intrinsic Value
$82.00
Price/Value
1.12x
Margin of Safety
-11.81%
Premium
11.81%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CL's realized 12.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CL trades at a 12% premium to its adjusted intrinsic value of $82.00, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 32.4x compares to the current market P/E of 33.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$84.28
Median 1Y
$86.49
5th Pctile
$60.53
95th Pctile
$123.64
Ann. Volatility
20.8%
Analyst Target
$101.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Noel Wallace Chairman,
President and Chief Executive Officer
$1,500,000 $8,005,152 $16,478,196
Shane Grant Operating
rating Officer, Americas
$592,308 $8,409,910 $11,924,112
Stanley J. Sutula
III Chief Financial Officer
$1,097,759 $2,070,858 $5,664,299
Panagiotis Tsourapas Operating
rating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.
$1,001,812 $1,312,348 $4,079,561
Jennifer M. Daniels
Chief Legal Officer and Secretary
$952,706 $1,298,310 $3,770,777

CEO Pay Ratio

70:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $16,478,196
Avg Employee Cost (SGA/emp): $235,208
Employees: 33,600

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
33,600
-1.2% YoY
Revenue / Employee
$606,607
Rev: $20,382,000,000
Profit / Employee
$63,452
NI: $2,132,000,000
SGA / Employee
$235,208
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 4.3% 3.2% 7.0% 6.2% 3.2% 3.5% 10.1% 28.8% 5.2% 4.6% 23.3% 96.3% 13.5% 7.0% 9.8% 7.1% 4.5% 16.0% 8.2% 4.3% 4.34%
ROA 17.0% 14.0% 13.0% 12.3% 12.0% 11.6% 10.0% 9.4% 9.8% 14.3% 15.9% 17.4% 17.5% 17.8% 17.4% 17.1% 17.0% 13.2% 12.6% 11.9% 11.89%
ROIC 42.7% 39.6% 42.2% 39.5% 35.2% 31.1% 33.8% 32.1% 35.3% 34.9% 42.4% 46.6% 47.7% 46.8% 47.0% 42.1% 43.1% 47.5% 48.6% 47.5% 47.50%
ROCE 33.1% 29.7% 27.8% 26.4% 25.2% 24.0% 22.2% 23.1% 24.1% 31.1% 35.9% 37.4% 37.4% 40.8% 42.8% 39.1% 38.2% 31.3% 30.4% 30.0% 30.03%
Gross Margin 59.5% 58.1% 58.4% 56.8% 57.1% 55.5% 56.7% 57.9% 58.7% 59.5% 59.9% 60.7% 61.1% 60.3% 60.8% 60.1% 59.4% 60.2% 60.6% 61.5% 61.48%
Operating Margin 22.4% 21.8% 22.5% 20.2% 20.5% 20.3% 20.0% 21.6% 21.6% 23.0% 23.2% 22.9% 22.1% 22.0% 22.2% 21.1% 21.4% 20.6% 21.7% 19.0% 18.95%
Net Margin 14.4% 3.4% 12.7% 13.4% 13.9% 0.1% 7.8% 10.4% 14.4% 14.5% 13.5% 14.5% 14.6% 14.9% 14.1% 14.5% 14.3% -0.7% 12.1% 12.9% 12.93%
EBITDA Margin 24.7% 11.1% 21.8% 22.5% 23.9% 7.0% 15.6% 22.6% 23.6% 24.2% 23.2% 24.3% 23.7% 24.4% 23.8% 23.8% 23.7% 6.6% 20.8% 21.8% 21.77%
FCF Margin 15.3% 15.8% 14.5% 13.5% 13.1% 10.4% 11.8% 12.6% 13.3% 15.6% 15.3% 16.8% 16.9% 17.6% 17.4% 16.9% 17.1% 17.8% 18.1% 18.3% 18.33%
OCF Margin 18.3% 19.1% 17.8% 17.0% 16.8% 14.2% 15.8% 16.6% 17.2% 19.2% 18.7% 19.8% 19.8% 20.4% 20.2% 19.6% 20.0% 20.6% 20.9% 21.2% 21.17%
ROE 3Y Avg snapshot only 11.95%
ROA 3Y Avg snapshot only 15.34%
ROIC 3Y Avg snapshot only 34.99%
ROIC Economic snapshot only 41.62%
Cash ROA snapshot only 26.54%
Cash ROIC snapshot only 66.28%
CROIC snapshot only 57.39%
NOPAT Margin snapshot only 15.17%
Pretax Margin snapshot only 13.97%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 39.25%
SBC / Revenue snapshot only 0.52%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 21.69 30.27 28.61 31.81 28.26 34.29 36.71 40.34 35.18 27.32 27.37 27.21 28.92 25.26 26.12 25.19 22.13 29.84 32.88 36.27 33.121
P/S Ratio 3.33 3.76 3.35 3.49 3.07 3.41 3.20 3.23 2.92 3.23 3.62 3.87 4.13 3.63 3.79 3.66 3.20 3.12 3.30 3.51 3.204
P/B Ratio 97.80 107.64 182.17 368.14 87.60 152.65 -9776.64 -943.66 -6203.83 103.17 310.75 628.15 190.71 344.40 208.48 104.39 75.16 1177.54 473.23 313.04 284.396
P/FCF 21.84 23.77 23.10 25.94 23.48 32.91 27.06 25.63 21.87 20.67 23.64 23.01 24.40 20.59 21.83 21.74 18.69 17.50 18.22 19.15 19.149
P/OCF 18.16 19.72 18.78 20.52 18.23 23.95 20.19 19.49 17.01 16.78 19.36 19.52 20.88 17.78 18.80 18.69 16.03 15.15 15.79 16.58 16.579
EV/EBITDA 14.68 19.00 17.84 19.43 17.53 20.76 21.24 21.29 19.19 16.92 17.05 17.76 18.74 16.71 17.23 16.85 14.82 17.82 19.33 20.94 20.939
EV/Revenue 3.72 4.16 3.73 3.90 3.48 3.88 3.64 3.67 3.32 3.65 3.99 4.23 4.47 3.99 4.14 4.03 3.55 3.45 3.61 3.82 3.818
EV/EBIT 16.79 22.24 21.05 23.05 20.79 24.78 25.59 25.59 23.02 19.56 19.54 20.32 21.46 19.12 19.71 19.26 16.96 21.20 23.13 25.15 25.145
EV/FCF 24.38 26.31 25.76 28.93 26.62 37.48 30.77 29.10 24.91 23.33 26.08 25.19 26.44 22.64 23.84 23.92 20.70 19.34 19.96 20.83 20.830
Earnings Yield 4.6% 3.3% 3.5% 3.1% 3.5% 2.9% 2.7% 2.5% 2.8% 3.7% 3.7% 3.7% 3.5% 4.0% 3.8% 4.0% 4.5% 3.4% 3.0% 2.8% 2.76%
FCF Yield 4.6% 4.2% 4.3% 3.9% 4.3% 3.0% 3.7% 3.9% 4.6% 4.8% 4.2% 4.3% 4.1% 4.9% 4.6% 4.6% 5.4% 5.7% 5.5% 5.2% 5.22%
EV/OCF snapshot only 18.035
EV/Gross Profit snapshot only 6.319
Acquirers Multiple snapshot only 18.491
Shareholder Yield snapshot only 3.13%
Graham Number snapshot only $4.08
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.09 1.09 1.09 1.17 1.17 1.28 1.23 1.17 1.16 1.11 1.06 1.06 1.04 0.92 0.85 0.89 0.93 1.00 1.02 1.03 1.026
Quick Ratio 0.70 0.67 0.67 0.72 0.71 0.76 0.76 0.73 0.74 0.71 0.70 0.70 0.68 0.58 0.54 0.57 0.60 0.64 0.67 0.67 0.671
Debt/Equity 13.02 12.86 23.70 47.54 13.26 23.12 -1484.50 -140.45 -969.33 14.88 37.78 70.54 19.39 40.15 22.78 12.48 9.84 147.93 54.99 33.29 33.292
Net Debt/Equity 11.40 11.50 20.97 42.43 11.75 21.19 — — — 13.30 32.08 59.68 15.96 34.23 19.17 10.46 8.12 124.07 45.20 27.49 27.487
Debt/Assets 0.48 0.52 0.48 0.51 0.51 0.59 0.55 0.55 0.54 0.55 0.52 0.53 0.50 0.53 0.50 0.50 0.48 0.49 0.48 0.47 0.468
Debt/EBITDA 1.75 2.05 2.08 2.25 2.34 2.76 2.84 2.79 2.63 2.16 1.88 1.82 1.76 1.77 1.72 1.83 1.75 2.02 2.05 2.05 2.047
Net Debt/EBITDA 1.53 1.83 1.84 2.01 2.07 2.53 2.56 2.54 2.34 1.93 1.60 1.54 1.45 1.51 1.45 1.54 1.44 1.70 1.69 1.69 1.690
Interest Coverage 20.66 18.64 17.91 16.72 24.57 18.39 14.48 12.94 12.17 15.50 16.96 17.20 17.60 17.35 16.77 16.17 15.57 12.37 12.31 12.53 12.533
Equity Multiplier 26.87 24.70 48.98 93.52 26.19 39.23 -2695.50 -253.55 -1782.56 26.92 72.05 133.98 38.56 75.69 45.86 24.89 20.46 302.41 114.55 71.14 71.144
Cash Ratio snapshot only 0.223
Debt Service Coverage snapshot only 15.051
Cash to Debt snapshot only 0.174
FCF to Debt snapshot only 0.491
Defensive Interval snapshot only 145.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.11 1.13 1.11 1.12 1.10 1.17 1.15 1.17 1.18 1.21 1.21 1.22 1.23 1.24 1.20 1.18 1.17 1.26 1.25 1.23 1.229
Inventory Turnover 4.23 4.18 3.98 3.99 4.02 4.11 3.95 3.98 4.09 4.06 4.03 4.07 4.02 4.05 3.88 3.90 3.86 4.05 3.94 3.87 3.873
Receivables Turnover 12.77 13.60 11.91 12.07 12.45 12.83 11.75 11.87 12.75 12.59 11.61 11.48 12.23 12.94 11.28 11.12 11.42 12.75 11.51 11.27 11.270
Payables Turnover 5.54 4.90 4.96 5.33 5.38 5.11 5.00 5.29 5.42 5.01 4.98 5.20 5.14 4.53 4.55 4.71 4.59 9.01 4.26 4.27 4.266
DSO 29 27 31 30 29 28 31 31 29 29 31 32 30 28 32 33 32 29 32 32 32.4 days
DIO 86 87 92 92 91 89 92 92 89 90 91 90 91 90 94 94 95 90 93 94 94.2 days
DPO 66 74 74 69 68 71 73 69 67 73 73 70 71 81 80 77 80 41 86 86 85.6 days
Cash Conversion Cycle 49 40 49 53 52 46 50 53 51 46 49 51 50 38 46 49 47 78 39 41 41.1 days
Fixed Asset Turnover snapshot only 4.537
Operating Cycle snapshot only 126.6 days
Cash Velocity snapshot only 15.362
Capital Intensity snapshot only 0.798
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 7.3% 5.8% 4.5% 3.6% 2.3% 3.1% 4.9% 5.5% 7.9% 8.3% 7.7% 7.0% 5.1% 3.3% 1.0% 0.1% -0.0% 1.4% 4.3% 5.2% 5.24%
Net Income -1.0% -19.6% -23.2% -28.8% -27.7% -17.6% -21.8% -23.0% -17.7% 28.9% 63.4% 89.7% 80.8% 25.7% 11.0% 2.4% 1.3% -26.3% -28.0% -30.0% -29.98%
EPS 0.8% -18.4% -22.5% -27.9% -27.0% -16.5% -20.8% -22.2% -16.6% 30.3% 64.8% 91.5% 81.8% 26.0% 11.4% 3.3% 2.9% -24.6% -26.4% -29.0% -29.05%
FCF -21.4% -16.7% -18.7% -10.4% -12.3% -32.6% -14.3% -1.2% 10.0% 63.4% 39.4% 42.5% 33.2% 16.6% 14.7% 0.4% 1.3% 2.5% 8.7% 14.5% 14.48%
EBITDA 2.4% -11.8% -16.7% -20.1% -19.8% -12.0% -14.1% -9.3% -6.0% 24.9% 47.2% 47.9% 44.7% 14.6% 3.7% 0.4% 0.3% -17.9% -18.9% -19.8% -19.77%
Op. Income 2.1% -0.5% -2.6% -5.3% -6.5% -5.8% -5.6% 0.1% 6.1% 12.1% 19.2% 18.0% 14.8% 8.1% 0.6% -3.7% -5.0% -4.2% -0.9% -0.5% -0.55%
OCF Growth snapshot only 13.67%
Asset Growth snapshot only -3.89%
Equity Growth snapshot only -66.38%
Debt Growth snapshot only -10.29%
Shares Change snapshot only -1.31%
Dividend Growth snapshot only 2.45%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 3.5% 3.9% 4.2% 4.7% 4.6% 4.6% 4.9% 5.4% 5.8% 5.7% 5.7% 5.4% 5.1% 4.9% 4.5% 4.2% 4.2% 4.3% 4.3% 4.1% 4.06%
Revenue 5Y 2.4% 2.8% 2.8% 3.1% 3.0% 3.1% 3.2% 3.5% 4.1% 4.6% 5.1% 5.3% 5.4% 5.1% 4.6% 4.6% 4.5% 4.4% 4.5% 4.3% 4.26%
EPS 3Y 9.0% -2.5% -3.5% -4.3% -5.3% -8.1% -13.2% -15.6% -15.0% -3.9% 0.4% 2.4% 3.5% 11.1% 13.3% 15.4% 16.0% 7.4% 10.6% 12.0% 11.97%
EPS 5Y 15.5% -1.3% -2.7% -3.0% -2.4% -1.4% -4.2% -6.5% -4.6% 0.1% 3.2% 5.5% 5.2% 5.0% 3.7% 3.5% 2.8% -3.3% -3.7% -4.7% -4.68%
Net Income 3Y 8.0% -3.4% -4.2% -5.1% -6.1% -9.0% -14.1% -16.5% -16.1% -5.1% -0.6% 1.3% 2.5% 10.1% 12.3% 14.4% 14.7% 6.1% 9.3% 10.8% 10.81%
Net Income 5Y 14.1% -2.4% -3.8% -4.1% -3.5% -2.5% -5.2% -7.4% -5.6% -0.8% 2.3% 4.5% 4.2% 4.1% 2.8% 2.5% 1.6% -4.6% -4.7% -5.7% -5.68%
EBITDA 3Y 1.8% -2.5% -3.1% -3.5% -3.5% -5.4% -8.1% -7.9% -8.3% -1.0% 1.8% 2.4% 2.9% 8.0% 9.5% 10.5% 10.9% 5.5% 7.4% 6.0% 6.02%
EBITDA 5Y 6.0% -2.3% -3.2% -3.4% -2.9% -3.7% -5.5% -5.3% -4.5% 0.4% 2.9% 3.8% 4.1% 3.9% 3.5% 3.0% 2.3% -1.8% -2.4% -2.9% -2.88%
Gross Profit 3Y 3.9% 3.9% 4.1% 4.0% 3.6% 3.3% 3.2% 3.8% 4.1% 4.2% 4.6% 4.7% 5.0% 5.4% 5.5% 5.6% 5.8% 6.2% 6.4% 6.2% 6.22%
Gross Profit 5Y 2.7% 2.6% 2.4% 2.3% 2.0% 1.8% 1.8% 2.3% 3.2% 4.1% 5.0% 5.5% 5.7% 5.6% 5.1% 5.0% 4.5% 4.1% 4.2% 4.1% 4.14%
Op. Income 3Y 0.3% 0.7% 1.0% 0.9% 0.2% -0.1% -1.0% 0.1% 0.4% 1.6% 3.1% 3.8% 4.4% 4.5% 4.2% 4.4% 5.0% 5.1% 5.9% 4.2% 4.17%
Op. Income 5Y 8.4% 0.6% -0.0% -0.9% -1.2% -1.3% -1.9% -1.1% 0.0% 1.5% 3.0% 3.9% 4.1% 3.8% 3.1% 2.6% 2.0% 1.7% 1.8% 1.4% 1.38%
FCF 3Y 2.5% 1.7% -1.6% -3.4% -4.7% -12.7% -9.8% -10.9% -8.8% -2.8% -1.0% 8.0% 8.7% 8.7% 11.1% 12.2% 14.0% 25.0% 20.2% 17.9% 17.87%
FCF 5Y 0.9% 1.6% -0.7% -1.4% -1.8% -5.8% -2.2% -1.2% 0.7% 3.0% 2.6% 4.9% 4.8% 4.9% 3.3% 0.2% 0.4% 1.9% 3.9% 7.7% 7.70%
OCF 3Y 2.5% 2.9% 0.7% 0.1% -0.4% -6.6% -4.1% -5.5% -4.1% 0.2% 1.3% 7.9% 7.7% 7.3% 9.0% 9.2% 10.3% 18.0% 14.4% 12.9% 12.87%
OCF 5Y 0.2% 1.1% -0.7% -0.7% -0.8% -3.5% -0.5% 0.3% 2.1% 4.2% 3.9% 5.6% 5.6% 5.6% 4.1% 1.3% 1.5% 2.5% 4.1% 7.2% 7.18%
Assets 3Y 8.1% 7.3% 6.9% 6.1% 2.7% 1.5% 2.4% 2.3% 1.2% 1.0% 1.6% 1.0% 1.8% 2.2% 1.9% 3.6% 2.4% 1.3% 0.9% 1.1% 1.14%
Assets 5Y 4.7% 4.4% 4.8% 4.5% 5.0% 4.4% 4.2% 5.1% 5.0% 6.2% 5.2% 4.6% 2.2% 1.3% 2.0% 2.9% 2.5% 0.5% 1.0% 1.0% 0.97%
Equity 3Y — — — — — 50.8% — — — -6.4% -4.2% -35.8% -9.7% -29.7% 4.2% 61.1% 11.2% -48.7% — — —
Book Value 3Y — — — — — 52.2% — — — -5.2% -3.3% -35.1% -8.8% -29.0% 5.1% 62.6% 12.5% -48.1% — — —
Dividend 3Y -1.4% 4.7% 4.5% 4.8% 4.7% 1.2% 1.4% 1.6% 1.9% 2.5% 2.0% 1.9% 2.0% 1.7% 1.8% 1.6% 1.8% 1.9% 1.8% 1.4% 1.42%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.67 0.83 0.87 0.87 0.87 0.90 0.89 0.89 0.92 0.95 0.97 0.99 0.98 0.98 0.98 0.97 0.95 0.96 0.97 0.97 0.965
Earnings Stability 0.75 0.02 0.00 0.01 0.00 0.07 0.19 0.28 0.23 0.24 0.07 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.01 0.01 0.005
Margin Stability 0.99 0.99 0.99 0.98 0.98 0.97 0.97 0.97 0.97 0.98 0.97 0.97 0.97 0.98 0.97 0.97 0.97 0.97 0.97 0.97 0.973
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 1.00 0.92 0.91 0.88 0.89 0.93 0.91 0.91 0.93 0.88 0.50 0.50 0.50 0.90 0.96 0.99 0.99 0.89 0.89 0.88 0.880
Earnings Smoothness 0.99 0.78 0.74 0.66 0.68 0.81 0.76 0.74 0.81 0.75 0.52 0.38 0.42 0.77 0.90 0.98 0.99 0.70 0.67 0.65 0.647
ROE Trend — -8.37 — 3.83 -1.22 0.86 — — — -0.23 — — — 9.52 — — — 30.76 4.73 -4.99 -4.985
Gross Margin Trend 0.01 -0.00 -0.01 -0.02 -0.03 -0.03 -0.03 -0.03 -0.02 -0.00 0.01 0.02 0.03 0.03 0.03 0.02 0.01 0.01 0.00 0.00 0.003
FCF Margin Trend -0.04 -0.03 -0.04 -0.05 -0.05 -0.08 -0.05 -0.02 -0.01 0.03 0.02 0.04 0.04 0.05 0.04 0.02 0.02 0.01 0.02 0.02 0.015
Sustainable Growth Rate 1.8% 72.0% 1.2% 78.2% 37.3% 18.6% -66.7% -4.4% -46.0% 1.1% 7.7% 36.3% 5.1% 2.7% 3.7% 2.7% 1.7% 2.3% 99.6% 45.8% 45.84%
Internal Growth Rate 7.9% 3.2% 2.4% 1.6% 1.4% 0.6% — — — 3.6% 5.5% 7.0% 7.1% 7.3% 7.1% 7.0% 6.8% 1.9% 1.5% 1.3% 1.27%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.19 1.54 1.52 1.55 1.55 1.43 1.82 2.07 2.07 1.63 1.41 1.39 1.39 1.42 1.39 1.35 1.38 1.97 2.08 2.19 2.188
FCF/OCF 0.83 0.83 0.81 0.79 0.78 0.73 0.75 0.76 0.78 0.81 0.82 0.85 0.86 0.86 0.86 0.86 0.86 0.87 0.87 0.87 0.866
FCF/Net Income snapshot only 1.894
OCF/EBITDA snapshot only 1.161
CapEx/Revenue 3.1% 3.3% 3.3% 3.6% 3.8% 3.9% 4.0% 4.0% 3.8% 3.6% 3.4% 3.0% 2.9% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.84%
CapEx/Depreciation snapshot only 0.931
Accruals Ratio -0.03 -0.07 -0.07 -0.07 -0.07 -0.05 -0.08 -0.10 -0.10 -0.09 -0.07 -0.07 -0.07 -0.08 -0.07 -0.06 -0.06 -0.13 -0.14 -0.14 -0.141
Sloan Accruals snapshot only 0.017
Cash Flow Adequacy snapshot only 1.841
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.6% 2.6% 2.9% 2.7% 3.1% 2.8% 2.9% 2.9% 3.1% 2.8% 2.5% 2.3% 2.1% 2.5% 2.4% 2.5% 2.8% 2.9% 2.7% 2.5% 2.49%
Dividend/Share $1.80 $1.99 $1.99 $2.02 $2.03 $2.03 $2.04 $2.07 $2.09 $2.12 $2.12 $2.15 $2.17 $2.18 $2.19 $2.21 $2.24 $2.27 $2.28 $2.26 $2.10
Payout Ratio 57.1% 77.5% 82.2% 87.3% 88.3% 94.7% 1.1% 1.2% 1.1% 76.0% 67.1% 62.3% 62.1% 61.9% 62.2% 61.9% 62.4% 85.5% 87.9% 89.4% 89.45%
FCF Payout Ratio 57.5% 60.9% 66.4% 71.2% 73.3% 90.9% 78.6% 73.2% 67.7% 57.5% 58.0% 52.7% 52.4% 50.5% 51.9% 53.5% 52.7% 50.2% 48.7% 47.2% 47.23%
Total Payout Ratio 1.3% 1.4% 1.5% 1.6% 1.5% 1.7% 1.7% 1.9% 1.9% 1.3% 1.2% 1.2% 1.2% 1.2% 1.1% 1.1% 78.1% 1.0% 1.1% 1.1% 1.13%
Div. Increase Streak 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number -0.04 0.14 0.15 0.15 0.15 0.03 0.04 0.04 0.05 0.06 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.05 0.05 0.04 0.036
Buyback Yield 3.2% 2.0% 2.3% 2.3% 2.3% 2.1% 1.8% 1.8% 2.3% 1.8% 2.0% 2.0% 1.8% 2.4% 2.0% 1.7% 0.7% 0.6% 0.6% 0.7% 0.66%
Net Buyback Yield 2.8% 2.0% 2.3% 2.3% 2.3% 2.1% 1.8% 1.8% 2.3% 1.8% 2.0% 2.0% 1.8% 2.4% 2.0% 1.7% 0.7% 0.6% 0.4% 0.4% 0.45%
Total Shareholder Return 5.5% 4.6% 5.2% 5.0% 5.4% 4.9% 4.7% 4.6% 5.4% 4.6% 4.5% 4.3% 4.0% 4.8% 4.4% 4.2% 3.5% 3.5% 3.1% 2.9% 2.91%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.73 0.70 0.70 0.69 0.68 0.67 0.66 0.61 0.63 0.68 0.69 0.72 0.73 0.73 0.73 0.74 0.74 0.70 0.70 0.69 0.693
Interest Burden (EBT/EBIT) 0.95 0.95 0.94 0.94 0.96 0.95 0.93 0.92 0.92 0.94 0.94 0.94 0.94 0.94 0.94 0.94 0.94 0.92 0.92 0.92 0.920
EBIT Margin 0.22 0.19 0.18 0.17 0.17 0.16 0.14 0.14 0.14 0.19 0.20 0.21 0.21 0.21 0.21 0.21 0.21 0.16 0.16 0.15 0.152
Asset Turnover 1.11 1.13 1.11 1.12 1.10 1.17 1.15 1.17 1.18 1.21 1.21 1.22 1.23 1.24 1.20 1.18 1.17 1.26 1.25 1.23 1.229
Equity Multiplier 25.20 22.90 54.07 50.17 26.52 30.47 101.26 307.10 52.74 31.81 146.18 554.36 77.04 39.51 56.02 41.15 26.56 121.71 65.47 36.52 36.525
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $3.15 $2.56 $2.42 $2.32 $2.30 $2.14 $1.92 $1.80 $1.92 $2.79 $3.16 $3.45 $3.49 $3.51 $3.52 $3.56 $3.59 $2.65 $2.59 $2.53 $2.53
Book Value/Share $0.70 $0.72 $0.38 $0.20 $0.74 $0.48 $-0.01 $-0.08 $-0.01 $0.74 $0.28 $0.15 $0.53 $0.26 $0.44 $0.86 $1.06 $0.07 $0.18 $0.29 $0.71
Tangible Book/Share $-6.87 $-6.08 $-6.38 $-6.41 $-6.12 $-5.84 $-6.36 $-6.42 $-6.28 $-5.68 $-5.99 $-6.08 $-5.82 $-5.86 $-5.78 $-6.00 $-5.84 $-5.72 $-5.57 $-5.41 $-5.41
Revenue/Share $20.49 $20.62 $20.71 $21.09 $21.16 $21.53 $22.01 $22.47 $23.13 $23.58 $23.92 $24.27 $24.44 $24.44 $24.25 $24.49 $24.80 $25.33 $25.83 $26.12 $26.42
FCF/Share $3.13 $3.26 $3.00 $2.84 $2.77 $2.23 $2.60 $2.83 $3.09 $3.68 $3.66 $4.08 $4.13 $4.31 $4.22 $4.13 $4.25 $4.52 $4.68 $4.79 $4.84
OCF/Share $3.76 $3.93 $3.69 $3.59 $3.56 $3.06 $3.49 $3.73 $3.97 $4.54 $4.47 $4.81 $4.83 $4.99 $4.89 $4.80 $4.95 $5.22 $5.40 $5.53 $5.59
Cash/Share $1.13 $0.98 $1.04 $1.02 $1.12 $0.93 $1.04 $0.99 $1.15 $1.17 $1.59 $1.62 $1.82 $1.53 $1.59 $1.73 $1.82 $1.60 $1.76 $1.70 $1.72
EBITDA/Share $5.19 $4.52 $4.33 $4.23 $4.20 $4.02 $3.77 $3.87 $4.01 $5.08 $5.60 $5.78 $5.83 $5.84 $5.83 $5.86 $5.94 $4.90 $4.83 $4.76 $4.76
Debt/Share $9.09 $9.27 $9.02 $9.51 $9.84 $11.11 $10.69 $10.81 $10.55 $10.99 $10.52 $10.53 $10.26 $10.35 $10.05 $10.73 $10.39 $9.93 $9.90 $9.75 $9.75
Net Debt/Share $7.96 $8.29 $7.98 $8.49 $8.72 $10.18 $9.65 $9.83 $9.40 $9.81 $8.93 $8.91 $8.44 $8.82 $8.46 $9.00 $8.57 $8.33 $8.14 $8.05 $8.05
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 6.884
Altman Z-Prime snapshot only 11.382
Piotroski F-Score 6 6 7 6 6 6 6 6 6 8 8 8 8 8 8 5 5 7 7 8 8
Beneish M-Score -2.53 -2.83 -2.72 -2.78 -2.80 -2.58 -2.85 -2.88 -2.93 -2.87 -2.69 -2.74 -2.73 -2.90 -2.85 -2.75 -2.69 -3.01 -3.06 -3.14 -3.140
Ohlson O-Score snapshot only -5.714
Net-Net WC snapshot only $-12.31
EVA snapshot only $2521071642.30
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A+
Credit Score 82.56 80.20 79.92 74.86 74.63 75.54 73.08 71.79 71.13 79.20 79.57 80.45 80.18 80.64 80.14 80.36 79.53 77.78 76.45 76.84 76.840
Credit Grade snapshot only 5
Credit Trend snapshot only -3.519
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms